| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mineralys Therapeutics, Inc. (MLYS) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. MLYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $233.48M | - | |
| Dir | 5.46M | $161.19M | - | |
| CEO | 689.3K | $20.36M | -15,730 | |
| Dir | 588.2K | $17.38M | - | |
| Other | 69.8K | $2.06M | -20,822 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Congleton Jon47 | Chief Executive Officer | Sell | 15,319 | $12.19 | $186,802.95 | -1.7% | +9.3% | +98.7% | |
| Apr 1, 2025 | Rodman David Malcom58 | Chief Medical Officer | Sale+OE | 55,771 | $15.76 | $879,008.48 | -12.3% | -2.2% | +90.8% | |
| Mar 13, 2025 | Samsara Biocapital Gp, LLC59 | 10% Owner | Buy | 600,000 | $13.50 | $8,100,000.00 | +11.8% | +15.2% | +94.0% | |
| Mar 13, 2025 | Slingsby Brian Taylor48 | Director, 10% Owner | Buy | 259,259 | $13.50 | $3,499,996.50 | +3.0% | +15.2% | +94.0% | |
| Mar 13, 2025 | Ra Capital Management, L.P.52 | Director | Buy | 1,296,296 | $13.50 | $17,499,996.00 | +43.4% | +15.2% | +94.0% | |
| Mar 13, 2025 | Akkaraju Srinivas81 | Director | Buy | 600,000 | $13.50 | $8,100,000.00 | +11.8% | +15.2% | +94.0% | |
| Jan 13, 2025 | Levy Adam Scott | CFO And Secretary | Sell | 10,757 | $9.10 | $97,863.90 | -2.3% | +48.7% | +251.9% | |
| Jan 13, 2025 | Congleton Jon47 | Chief Executive Officer | Sell | 18,333 | $9.06 | $166,082.31 | -2.0% | +48.7% | +251.9% | |
| Nov 11, 2024 | Rodman David Malcom58 | Chief Medical Officer | Sale+OE | 5,026 | $15.00 | $75,398.04 | -3.4% | -36.3% | +215.8% | |
| Nov 6, 2024 | Rodman David Malcom58 | Chief Medical Officer | Sale+OE | 25,482 | $15.03 | $383,065.81 | -15.8% | -31.7% | +147.6% |